Search

Issue
Title
Authors
Avastin in clinical chemotherapy of malignant tumors
Gorbunova V.A.
HPV-associated lesions in the Russian Federation: assessment of the problem
Briko N.I., Lopukhov P.D., Kaprin A.D., Novikova E.G., Trushina O.I., Khaldin A.A., Isaeva D.R., Skvortsova A.I.
Renal cell carcinoma associated with von Hippel–Lindau syndrome: an ambispective study
Volkova M.I., Turupaev K.A., Filippova M.G., Ladyko D.D., Sinitsyna O.R., Gridneva Y.V., Matveev V.B.
First results of a multicenter, non-randomized, prospective phase II study of the efficacy and safety of induction therapy with pembrolizumab, cisplatin, and 5-fluorouracil in patients with unresectable squamous cell carcinoma of the oropharynx, hypopharynx and larynx
Stativko O.A., Pokataev I.A., Kravtsov S.A., Zhukova L.G., Stroyakovskiy D.L., Sabitov E.R., Kuzmina E.S., Feoktistova P.S., Antonova T.G., Lyadova M.A., Nosova M.V., Sydykova R.S., Lisitsyna K.N., Strelnikova T.B., Alizade G.R., Parts S.A., Dolov M.M., Tedeeva A.K., Galkin V.N.
Basal cell skin carcinoma: Epidemiology of locally advanced and metastatic forms based on the data of the N.N. Blokhin National Medical Research Center of Oncology: A retrospective study
Orlova K.V., Martynova M.V., Petenko N.N., Nazarova V.V., Demidov L.V.
Laparoscopic pelvic exenteration for malignant tumors of the female reproductive system: a case series
Lyadov V.K., Nevrov A.S., Garipov M.R., Moskalenko A.N., Simbiryov T.V., Galkin V.N.
A clinical case of treatment of recurrent inoperable locally advanced breast cancer using conformal radiotherapy. Case report
Medvedev S.V., Vlasova M.Y., Bolotina L.V., Kaprin A.D., Khmelevskiy E.V., Zikiryakhodzhaev A.D., Khakimova S.G., Khakimova G.G., Bychkova N.M., Zaitseva N.A., Abushova E.R., Guseva S.D., Maslov E.D.
Following in the footsteps of SABCS 2022: top 16 early breast cancer studies that could change our clinical practice: A review
Kolyadina I.V.
Diagnosis of renal cell carcinoma in patients with prostate cancer: capabilities of PET/CT with 18F-PSMA-1007
Ognerubov N.A., Mirsalimova O.O., Antipova T.S.
Disability-Adjusted Life Year (DALY) assessment and economic damage from premature death of cervical uterine and ovarian cancers in the Tomsk Region
Zhuikova L.D., Ananina O.A., Sirotina A.S., Pikalova L.V., Fokin V.A., Kononova G.A.
Erythropoietin as an adjuvant treatment with (chemo) radiation therapy for head and neck cancer (Russian Translation of Cochrane Plain Language Summary – PLS)
Alexandrova E.G.
Characteristics of the receptor phenotype of tumor-associated immune cells of the epithelial-mesenchymal microenvironment of ovarian cancer
Zhurman V.N.
PARP (Poly ADP‐Ribose Polymerase) inhibitors for locally advanced or metastatic breast cancer (Russian Translation of Cochrane Plain Language Summary)
Uvarova K.G.
Experience in the treatment of radioinduced angiosarcoma of the breast in a patient with primary multiple lesions of the breast and bladder. Case report
Semenov E.V., Gasymly D.D., Zyuzyukina A.V., Zukov R.A.
New therapies for hormone-positive HER2-negative metastatic breast cancer with AKT signaling alterations: the Expert Panel Decision
Editorial B.
The ability to combine autodermoplasty in the treatment of patients with malignant tumors of the skin extremities (clinical observation)
Vaschenko L.N., Dashkova I.R., Kechedzhieva E.E., Babieva S.M.
Role of repeat biopsies of metastatic and recurrent lesions for the study of tumor heterogeneity in luminal breast cancer: Retrospective and prospective analyses
Gluzman M.I., Chistyakova E.A., Raskin G.A., Orlova R.V.
The combination of lenvatinib and pembrolizumab in the treatment of patients with metastatic kidney cancer and factors of poor prognosis: experience of clinics in Moscow: A prospective observational study
Pokataev I.A., Stroyakovskiy D.L., Fedyanin M.Y., Zhukova L.G., Stativko O.A., Andreyashkina I.I., Volkova M.I., Volkonskiy M.V., Polshina N.I., Kotova E.V., Kravchuk D.A., Bystrov A.A., Antonova T.G., Lyadova M.A., Kuzmina E.S., Parts S.A., Salpagarov M.K., Galkin V.N., Klimov A.V.
Endoscopic criteria for early differential diagnosis of gastritis-like form of primary non-Hodgkin's lymphomas and gastric cancer: A prospective study
Lozovaia V.V., Malikhova O.A., Tumanyan A.O., Gusarova O.A.
Rare histological subtypes of bladder cancer in clinical practice: a case series
Paychadze A.A., Golubeva S.A., Kamalova M.A.
Diagnostic potential of endosonography in primary and secondary esophageal tumors: retrospective study
Khalaev Z.V., Suleymanov E.A., Malikhova O.A., Tumanyan A.O., Krylovetskaia M.A., Kontsevaya A.Y., Salimova A.A., Makarova M.V.
The era of immuno-oncology in onco-urology: what have we achieved? The review of the symposium of the alliance between Merck and Pfizer held within the framework of the XXV Russian Oncology Congress. November 9, 2021
Editorial B.
Cabazitaxel in the treatment of metastatic castration-resistant prostate cancer
Ognerubov N.A.
Squamous cell breast cancer: description of a rare clinical case
Zikiryakhodjaev A.D., Khakimova S.G., Rasskazova E.A., Saribekian E.K., Omarova D.F., Surkova V.S., Khakimova G.G.
PARP inhibitors in female reproductive system cancers
Pokataev I.A., Tyulyandin S.A.
Efficacy and safety of pemetrexed maintenance therapy in advanced non-small-cell lung cancer: a review of phase III studies
Kit O.I., Vladimirova L.Y., Sholokhova E.A.
Denosumab (AMG-162) v profilaktike osteoporoza, vyzvannogo priemom ingibitorov aromatazy u bol'nykh rakom molochnoy zhelezy v ad\"yuvantnoy terapii i u bol'nykh rakom predstatel'noy zhelezy pri polnoy androgennoy blokade
Lichinitser M.R., Semenov N.N.
Neksavar® (sorafenib)v lechenii rasprostranennogo pochechno-kletochnogo raka
Podregul'skiy K.E.
Estramustina fosfat (estratsit) v lechenii raka predstatel'noy zhelezy (po materialam Journal of Clinical Oncology, 2005 ASCO Proceedings)
Podregul'skiy K.E.
Intermediate results of the PERFECTION observational study in a population of patients with metastatic, persistent and recurrent cervical cancer
Saevets V.V., Kuzmin N.K., Ponomareva N.A., Krashikhina T.V., Mochalova A.S., Vasilyev L.A., Stroyakovsky D.L., Kolomiets L.A., Averyanova S.V., Yavorskaya M.A., Orlova S.A., Boskhomjieva M.V., Peganova E.V., Shalina A.I., Kosukhina A.A., Khaikin A.M., Shkradyuk A.V., Bobrova E.A., Dikhtyar T.N., Shikina V.E., Sultanbaev A.V., Kudryavtsev I.Y., Zinkina-Orikhan A.V., Fogt S.N., Kiseleva P.V., Svechnikov E.V.
Cardiovascular toxicity of chemotherapy and thyroid status of patients with gastric and colon cancer: Current state of the problem. A review
Stanoevich I.V., Ioutsi V.A., Lysovolenko N.L., Alekseev I.E., Kondrashkina A.D., Polianskii M.B., Pis'mennaia E.V.
Benefits and limitations of breastfeeding for mothers with malignant tumors
Ladodo O.B., Iurova M.V., Khokhlova S.V., Rodionov V.V., Sheshko E.L., Zubkov V.V., Makieva M.I., Chutkova D.A., Akhapkina E.S., Degtyarev D.N.
Real-world experience with trastuzumab deruxtecan in patients with metastatic HER2-positive breast cancer and HER2-positive gastric cancer: A retrospective study
Evdokimov V.I., Bloshchinenko A.A., Abolmasov A.E., Vilensky A.A., Laskov M.S.
Following in the footsteps of SABCS 2022: top 12 advanced breast cancer studies that could change our clinical practice: A review
Kolyadina I.V.
Cabozantinib in the treatment of patients with advanced renal cell carcinoma
Volkova M.I., Turupaev K.A., Kalinin S.A.
Modern ultrasound technologies in monitoring the effectiveness of chemotherapy for cervical cancer
Musaeva Z.R., Chekalova M.A., Mesheryakov A.A.
The potential use of oncolytic viruses in breast cancer: historical aspects and future prospects (literature review)
Morozov D.A., Kolyadina I.V., Poddubnaya I.V., Chumakov P.M., Ilinskaya G.V., Bokhian V.Y., Sopova M.I.
Adenosquamous carcinoma of the colon: case report
Nefedova N.A., Kharlova O.A., Malkov P.G., Kharlov N.S., Danilova N.V.
Fraksiparin kak osnovnoe sredstvo profilaktiki tromboembolii legochnoy arterii v posleoperatsionnom periode u bol'nykh kolorektal'nym rakom
Makarov O.G.
Prognostic significance of primary and interval cytoreductive surgery in late-stage ovarian cancer. A retrospective study
Zhurman V.N., Nechushkina V.M., Maslennikova A.V.
Clinical and morphological features of breast tumors with PIK3CA mutations in Russian patients: Observational study
Sokolova T.N., Solov'eva T.I., Aleksakhina S.N., Janus G.A., Goryainova A., Gluzman M.I., Orlova R.V., Stukan A.I., Zukov R.A., Zyuzyukina A.V., Murunova Y.N., Sultanbaev A.V., Vorobeva E.N., Mikhaevich L.M., Pyliv V.N., Lysenko A.N., Khachmamuk Z.K., Kozlov A.E., Bakharev S.Y., Parsyan S.G., Rossokha E.I., Osidze L.D., Shumskaya I.S., Agaeva A.V., Kasmynina T.A., Klimenko V.V., Akhmetgareeva K.T., Vakhitova A.A., Chakhkieva M.D., Dmitriev V.N., Bakshun Y.I., Vasilyev A.E., Gasimly D.D., Kravchenko N.A., Maksimov D.A., Nesterova A.I., Sharvashidze I.O., Gadzaova C.H., Rakhmankulova G.G., Khamgokov Z.M., Amirkhanova I.K., Bembeeva L.V., Vladimirov V.I., Petrenko O. ., Ruskova N.G., Serikova E.L., Subbotina K.S., Tkachenko S.A., Chang V.L., Erdniev S.P., Barbara V.S., Vasilevskaya A.V., Mikheeva Y.V., Popova N.O., Startseva E.P., Fateeva A.V., Yukalchuk D.Y., Grechkina A.A., Musaeva K.S., Odintsova S.V., Stel'makh A.S., Khabibulaeva P.I., Khlobystina A.G., Shvaiko K.A., Basova E.A., Bogomolova I.A., Bolieva M.B., Goldberg V.E., Kibisheva M.V., Menshikov K.V., Ryazanov D.V., Stepanova M.L., Udalova Y.A., Shkradyuk A.V., Chapko Y.S., Shchukina A.A., Khabriev I.M., Kirtbaya D.V., Degtyarev A.M., Epkhiev A.A., Tyugina Y.A., Murachuev M.A., Togo A.V., Ievleva A.G., Imyanitov E.N.
Osimertinib for the first-line treatment of EGFR-positive non-small cell lung cancer
Reutova E.V., Laktionov K.P., Iudin D.I., Neliubina L.A., Gorokhova G.K., Egorova A.V.
Clinical cases of treatment of hepatocellular carcinoma
Lazarev S.A., Mamontov K.G., Manihas G.M., Antimonik N.Y.
Lechenie metastazov kolorektal'nogo raka v pecheni
Patyutko Y.I., Sagaydak I.V., Pylev A.L., Podluzhnyy A.N., Chuchuev E.S., Shishkina N.A.
Primenenie tsetuksimaba v lechenii ploskokletochnogo raka golovy i shei
Romanov I.S., Kupchan D.Z.
Results of lenvatinib as first-line targeted therapy for advanced hepatocellular cancer: a retrospective study
Antonova E.Y., Janyan I.A., Laktionov K.K., Pogrebnyakov I.V., Savchenko I.V., Breder V.V.
The molecular basis of thyroid status formation and its role in the initiation and promotion of gastric and colorectal cancer: A review
Stanoevich I.V., Ioutsi V.A., Lysovolenko N.L., Alekseev I.E., Kondrashkina A.D., Polyansky M.B., Pis'mennaia E.V.
Membrane (CD8⁺PD-1⁺ and CD4+PD-1⁺) and soluble (sPD-1 and sPD-L1) forms of immune checkpoints in melanoma, breast cancer, and oral mucosal cancer patients: A observational study
Zabotina T.N., Chertkova A.I., Borunova A.A., Kushlinskii N.E., Gershtein E.S., Zakharova E.N., Shoua E.K., Tsiklauri V.T., Samoylenko I.V., Khoroshilov M.V., Kadagidze Z.G.
Place of durvalumab in the treatment of biliary tract cancer: A review
Breder V.V., Ledin E.V., Chubenko V.A., Orlova R.V., Petkau V.V., Pokataev I.A.
Place of CDK 4/6 and PARP inhibitors in the modern treatment approach of HER2-negative breast cancer
Editorial B.
Clinical prognostic factors of bilateral synchronous renal cancer
Komarov M.I., Matveev V.B., Volkova M.I., Komarov I.G., Ridin V.A.
Anxiety and cognitive impairment in elderly patients with gastrointestinal cancers
Stilidi I.S., Kotyukova A.Y., Lyadov V.K.
Passive smoking prevalence among patients of krasnoyarsk regional oncologic dispensary
Kutumova O.Y., Kononova L.I., Dobretsova E.A., Shulmin A.B., Korotkova K.M., Rossiyeva T.V.
Klinicheskie sluchai lecheniya gepatotsellyulyarnogo raka v Rossii. Klinicheskiy sluchay 1 Bolee chem 3-letnyaya stabilizatsiya protsessa gepatotsellyulyarnogo raka na fone dlitel'nogo priema preparata sorafenib
Sheko S.S., Dem'yanova G.A.
Keliks (pegilirovannyy liposomal'nyy doksorubitsin) v programmnoy terapii 2-y linii metastaticheskogo raka molochnoy zhelezy
Interim results analysis of the PERFECTION observational study in patients with metastatic non-small cell lung cancer
Laktionov K.K., Fedyanin M., Stroyakovskiy D.L., Mochalova A.S., Iasieva A.R., Fadeeva N.V., Shapovalova I.S., Mironov O.V., Dergunov A.S., Orlov S.V., Vasilev L.A., Bobrova E.A., Orlova S.A., Kosukhina A.A., Polshina N.I., Vardanian S.G., Fedoseev A.I., Tumasian K.S., Danilova A.E., Krashikhina T.V., Tsygankova E.I., Staritsyn D.E., Toporkova O.V., Boskhomdzhieva M.V., Sultanbaev A.V., Edamenko M.V., Dmitriev V.N., Shkradiuk A.V., Shkret K.A., Prosianikova O.N., Svechnikov E.V., Grigorchuk S.Y.
Determination of sentinel lymph nodes in gynecological cancer using the radiopharmaceutical Sentiscan. A case series
Shevchuk A.S., Krylov A.S., Knyazev R.I., Afanasieva K.V.
Which faecal blood test is more accurate in detecting bowel cancer and large polyps in population screening? (Russian Translation of Cochrane Plain Language Summary (PLS))
Plyakhina K.S.
Malignant neoplasm of the bronchi and lung: Russian clinical guidelines
Laktionov K.K., Artamonova E.V., Borisova T.N., Breder V.V., Bychkov I.M., Vladimirova L.I., Volkov N.M., Ergnian S.M., Zhabina A.S., Kononets P.V., Kuz’minov A.E., Levchenko E.V., Malikhova O.A., Marinov D.T., Miller S.V., Moiseenko F.V., Mochal’nikova V.V., Novikov S.N., Pikin O.V., Reutova E.V., Rodionov E.O., Sakaeva D.D., Semenova A.I., Smolin A.V., Sotnikov V.M., Tuzikov S.A., Turkin I.N., Tiurin I.E., Chkhikvadze V.D., Kolbanov K.I., Chernichenko A.V., Fedenko A.A., Filonenko E.V., Nevol’skikh A.A., Ivanov S.A., Khailova Z.V., Gevorkian T.G., Butenko A.V., Gil’mutdinova I.R., Gridneva I.V., Eremushkin M.A., Zernova M.A., Kasparov B.S., Kovlen D.V., Kondrat’eva K.O., Konchugova T.V., Korotkova S.B., Krutov A.A., Obukhova O.A., Ponomarenko G.N., Semiglazova T.I., Stepanova A.M., Tkachenko G.A., Khulamkhanova M.M.
Regorafenib: from clinical research to clinical practice
Fedyanin M.Y., Tryakin A.A.
Current algorhytm of screening and early diagnosis of hepatocellular carcinoma
Tikhonov I.N., Pavlov C.S., Mayevskaya M.V., Ivashkin V.T.
Experience with olaparib in the treatment of BRCA-associated tumors in real clinical practice. Observational study
Sultanbaev A.V., Menshikov K.V., Musin S.I., Nasretdinov A.F., Fatikhova A.A., Izmailov A.A., Lipatov O.N., Ayupov R.T., Sultanbaeva N.I., Menshikova I.A., Serebrennikov G.A.
Supportive therapy for ovarian cancer
Pokataev I.A., Tyulyandin S.A.
A population-based portrait of breast cancer in russia: a cancer register-based analysis in russian
Poddubnaya I.V., Kolyadina I.V., Kalashnikov N.D., Borisov D.A., Makarova M.V.
Targetnaya terapiya rasprostranennogo raka pochki: problema vybora preparata na primere mul'tikinaznykh ingibitorov
Matveev V.B.
Tsetuksimab pri lechenii metastaticheskogo kolorektal'nogo raka
Sekacheva M.I., Skipenko O.G.
Novel therapies for the metastatic HER2-positive breast cancer with metastases in the central nervous system: a clinical case
Radyukova I.M., Rats N.M.
Comparison of the efficacy of neoadjuvant chemotherapy with FLOT regimen and adjuvant chemotherapy with XELOX/FOLFOX regimen in patients with locally advanced gastric cancer: A retrospective study
Semenov N.N., Izrailov R.E., Semenov N.E., Zhukova L.G., Feoktistova P.S., Matveychuk D.A., Khatkov I.E.
Malignant neoplasm of the bronchi and lung: Russian clinical guidelines
Laktionov K.K., Artamonova E.V., Borisova T.N., Breder V.V., Bychkov I.M., Vladimirova L.I., Volkov N.M., Ergnian S.M., Zhabina A.S., Kononets P.V., Kuzminov A.E., Levchenko E.V., Malikhova O.A., Marinov D.T., Miller S.V., Moiseenko F.V., Mochal’nikova V.V., Novikov S.N., Pikin O.V., Reutova E.V., Rodionov E.O., Sakaeva D.D., Sarantseva K.A., Semenova A.I., Smolin A.V., Sotnikov V.M., Tuzikov S.A., Turkin I.N., Tyurin I.E., Chkhikvadze V.D., Kolbanov K.I., Chernykh M.V., Chernichenko A.V., Fedenko A.A., Filonenko E.V., Nevol’skikh A.A., Ivanov S.A., Khailova Z.V., Gevorkian T.G., Butenko A.V., Gil’mutdinova I.R., Gridneva I.V., Eremushkin M.A., Zernova M.A., Kasparov B.S., Kovlen D.V., Kondrat’eva K.O., Konchugova T.V., Korotkova S.B., Krutov A.A., Obukhova O.A., Ponomarenko G.N., Semiglazova T.I., Stepanova A.M., Khulamkhanova M.M.
Dual immunological blockade in the treatment of metastatic non-small cell lung cancer: reality and perspectives
Yudin D.I., Laktionov K.K., Laktionova L.V., Breder V.V.
The role of bevacizumab in the treatment of patients with ovarian and cervical cancer
Khokhlova S.V.
Preclinical studies of cytotoxicity and cytostatic activity of five new imidazotriazine derivatives in MDA-MB231, BT474, and MCF-7 breast cancer cell cultures
Al-Humairi A.H., Buldakov M.A., Novochadov V.V., Cherdyntseva N.V., Udut V.V.
Clinical factors of the risk of hyperplastic endometry processes on tamoxifen therapy with breast cancer: Retrospective population study
Golubenko E.O., Savelyeva M.I., Poddubnaya I.V., Korennaya V.V.
Second primary cancer in patients with head and neck squamous cell carcinoma: case report
Agabekyan G.O., Stelmakh D.K., Aydarbekova A.A.
The role of targeted therapy in the treatment of advanced hepatocellular carcinoma
Shakhnovich E.B., Kerbikov O.B., Kulaga E.A.
Mesto tsetuksimaba v terapii metastaticheskogo raka tolstoy kishki
Artamonova E.V.
Prognostic significance of androgen receptor expression in triple-negative breast cancer
Panchenko I.S., Panchenko S.V., Sharafutdinov M.G., Rodionov V.V., Kometova V.V., Burmenskaya O.V.
Do cancer vaccines help people with advanced non-small cell lung cancer? (Russian translation of the Plain Language Summary (PLS) of the Cochrane Systematic Review)
Editorial B.
Scalp hypothermia for the prevention of chemotherapy-induced alopecia in breast cancer
Ognerubov N.A., Barsukov S.V.
Effect of transfused donor and autoerythrocytes on the oncological outcomes of surgical treatment in patients with renal cell carcinoma with tumor-related venous thrombosis: observational study
Volkova M.I., Feoktistov P.I., Begaliev A.K., Shin A.R., Matveev V.B., Prikhodchenko A.O.
The effect of CDK4/6 inhibitors on the overall survival in patients with advanced HR+/HER2- BC in the entire population and in special clinical subgroups of unfavorable prognosis: A review
Grechukhina K.S., Kalugin M.V., Prosvirnov A.A., Sukhova M.V., Zhukova L.G.
Combination therapy regimens in the treatment of metastatic renal cell carcinoma: A review
Zukov R.A., Chernyaev D.V., Zulkaidarova A.R.
Assessment of the impact of the use of durvalumab for the treatment of advanced small cell lung cancer on the achievement of the target "reduction in mortality from neoplasms"
Ryazhenov V.V., Orlov S.V., Ivakhnenko O.I.
Laparoscopic resections of the liver and the colon in patients with synchronous colorectal metastases: a case series
Lyadov V.K., Moskalenko A.N., Britskaia N.N.
Modern possibilities of immunotherapy in the treatment of extensive-stage small cell lung cancer: experience of durvalumab application. Case report
Zhabina A.S., Moiseenko F.V., Volkov N.M., Abduloeva N.K., Moiseenko V.M.
Antiangiogenic therapy for breast cancer with triple negative phenotype
Ganshina I.P., Ivanova K.A., Gordeeva O.O., Arkhipov A.V., Zhukova L.G.
The virtual forum on the diagnosis and treatment of PIK3CA-mutated metastatic breast cancer. October 16th, 2020. Event review
Poddubnaya I.V., Gligorov J., Zhukova L.G., Kovalenko E.I., Frolova M.A.
Reduction of febrile neutropenia by using long-acting granulocyte colony-stimulating factors in patients with solid tumors receiving every-2-week chemotherapy
Kononenko I.B., Snegovoy A.V., Grebennikova O.P., Sel’chuk V.Y., Palchinskaia O.V.
Serous borderline ovarian tumors: modern possibilities of ultrasound diagnostics in monitoring the course of the disease after organ-preserving operations
Davydova I.I., Chekalova M.A., Karseladze A.I., Kuznetsov V.V., Meshcheriakova L.A., Dedy T.V., Cherkasov E.I., Zharova A.S.
The role of a multidisciplinary approach in the treatment of hepatocellular carcinoma
Kit O.I., Vladimirova L.I., Storozhakova A.E., Snezhko T.A., Kalabanova E.A., Samaneva N.I., Svetitskaia I.V., Kabanov S.N.
Durvalumab in the treatment of locally advanced non-small cell lung cancer after chemoradiotherapy in a real practice
Sakaeva D.D., Ruchkin V.V., Goncharova O.V., Abbasova R.R., Mufazalov F.F.
Lung cancer in the Tomsk region (epidemiological aspects)
Choynzonov E.L., Zhuikova L.D., Ananina O.A., Odintsova I.N., Pikalova L.V.
The effectiveness of targeted therapy in the treatment of common forms of ovarian cancer
Saevets V.V., Vazhenin A.V., Chernova L.F., Shimotkina I.G., Kurchenkova O.V., Mukhin A.A., Taratonov A.V.
Ribociclib in 1st line HR+ breast cancer treatment
Zhukova L.G., Ganshina I.P., Gordeeva O.O., Lubennikova E.V.
Clinical cases of the treatment of metastatic colorectal cancer in Russia
Goldberg V.E., Hasanova A.I., Shkuratova V.V., Belevich Y.V., Popova N.O., Simolina E.I., Vysockaya V.V., Dudnikova E.A., Kravchuk T.L., Minnabetdinova R.R., Nekrasova O.V.
Using of multi-kinase inhibitor regorafenib for metastatic colorectal cancer
Kit O.I., Vladimirova L.Y., Abramova N.A., Storozhakova A.E., Popova I.L., Tikhanovskaya N.M., Lyaynova A.A., Ryadinskaya L.A.
Predictive factors of achievement pathological complete response at neoadjuvant chemotherapy of primary operable breast cancer
Pavlikova O.A., Kolyadina I.V., Komov D.V., Vishnevskaya Y.V., Poddubnaya I.V.
Surgical treatment and clinicopathological characteristics of patients with neuroendocrine neoplasms of the stomach
Bokhyan V.Y., Peregorodiev I.N., Delektorskaya V.V., Arkhiri P.P., Stilidi I.S.
Cost-effectiveness of empegfilgrastim (Extimia®) for the prevention of severe neutropenia in patients with malignant neoplasm of female breast
Rudakova A.V., Tolkacheva D.G., Gavrilova O.N., Vaganov A.S.
Insulin-like growth factors in patients with ovarian tumors (results of own research)
Knyazev R.I., Kuznetsov V.V., Bokin I.I., Barinov V.V., Kushlinskiy N.E., Poddubnaya I.V.
Latent herpes virus infection in the carcinogenesis of bladder cancer
Loran O.B., Sinyakova L.A., Gundorova L.V., Kosov V.A., Kosova I.V., Kolbasov D.N., Kononkov I.V.
Comparative evaluation of the efficacy of an incomplete cytoreduction application in combination with systemic therapy and systemic therapy as mono-therapy in patients with metastatic clear-cell renal cell carcinomas
Borisov P.S., Orlova R.V., Shkolnik M.I., Karlov P.A.
The use of combined plastic interventions in the reconstruction of post-operative soft tissue defects of the chest wall in the surgical treatment of locally advanced breast cancer
Vashenko L.N., Daschkova I.R., Bakulina S.M., Andreyko E.A.
Clinical case long-term care of the patient with mCRPC
Zaborskiy I.N., Karjakin O.B.
Pharmacoeconomic usefulness of the drug Giotrif® (afatinib) in first-line treatment of locally advanced or metastatic non-small cell lung cancer with a mutation of epidermal growth factor receptor (EGFR)
Kolbin A.S., Kurylev A.A., Pavlysh A.V., Proskurin M.A., Balykina Y.Y.
Modern possibilities of HER2 positive breast cancer treatment (based on clinical trials)
Kolyadina I.V., Poddubnaya I.V.
Difficulties in treating patients with breast cancer in Russia: the resolution on the results of the Review Board
Artamonova E.V., Gorbunova V.A., Zhukov N.V., Manzjuk L.V., Manihas A.G., Paltuev P.M., Semiglazov V.F., Semiglazova T.Y., Stenina M.B., Tjuljandin S.A., Chubenko V.A.
Selection of the anti-angiogenesis therapy for the first-line chemotherapy in advanced ovarian cancer
Khokhlova S.V.
The efficiency of trabectedin in the monotherapy and combinations in the treatment of advanced ovarian cancer
Cherkasova M.V., Khokhlova S.V., Limareva S.V., Bazaeva I.Y., Orel N.F., Gorbunova V.A., Poddubnaya I.V.
Antiangiogennaya terapiya disseminirovannogo kolorektal'nogo raka
Meshcheryakov A.A.
Press-reliz44-e ezhegodnoe zasedanie Evropeyskoy assotsiatsii po izucheniyu pecheni (EASL)
Press-reliz Novaya era v lechenii raka pochki
Effektivnost' ad\"yuvantnoy terapii anastrozolom i tamoksifenom u patsientok s rannimi stadiyami raka molochnoy zhelezy (analiz dannykh issledovaniya ATAC pri mediane vremeni nablyudeniya 100 mes)
Sravnitel'noe issledovanie opredeleniya NER2-statusa raka molochnoy zhelezy metodami immunogistokhimii i in situ gibridizatsii
Zavalishina L.E., Andreeva Y.Y., Ryazantseva A.A., Bateva M.V., Frank G.A.
Rak zheludka: standarty i individual'nye aspekty taktiki khirurgicheskogo lecheniya
Khvastunov R.A., Danilov S.P.
Analiz sostoyaniya onkoginekologicheskoy pomoshchi v navoiyskom regione (Respublika Uzbekistan)
Kudryavtsev I.Y., Kerimov R.A.
Takticheskie podkhody k lecheniyu regionarnykh metastazov u bol'nykh rakom gortani, gortanoglotki, slizistoy obolochki polosti rta i rotoglotki
Aydarbekova A., Lyubaev V.L., Tkachev S.I., Alieva S.B., Brzhezovskiy Z.
Sovremennye vozmozhnosti lekarstvennoy terapii operabel'nogo raka molochnoy zhelezy (po materialam St. Gallen, 2005)
Letyagin V.P., Vysotskaya I.V.
«Problema optimizatsii ad\"yuvantnoy endokrinnoy terapii na rannikh stadiyakh raka molochnoy zhelezy»
Semiglazov V.F., Poddubnaya I.V.
Blood management of patients with stage II–III colorectal cancer: Results of a comparative study
Lyadov V.K., Kornev D.O., Moskalenko A.N., Galkin V.N.
Current technologies of response assessment in rectal cancer after neoadjuvant treatment: A review
Orlov A.E., Kaganov O.I., Frolov S.A., Blinov N.V., Okulevich N.B.
Results of pelvic exenteration in patients with cervical cancer: clinical experience
Khakimov G.A., Khakimova G.G.
Remote multimodal prehabilitation in the presence of cachexia and resectable gastric cancer: a clinical case
Lyadov V.K., Boldyreva T.S., Achkasov E.E., Gorshkov A.Y., Chashchin M.G., Protsenko E.V., Starodubova V.V., Galkin V.N.
Safety and toxicity of cabozantinib monotherapy in patients with advanced renal cell carcinoma: a Russian multicenter observational study
Volkova M.I., Kalpinskiy A.S., Menshikov K.V., Gorbuleva L.V., Sultanbaev A.V., Evsyukova O.I., Meltonian V.R., Mishugin S.V., Maturov M.R., Olshanskaya A.S., Shemetov D.I., Sannikova T.A., Makhnutina M.V., Filipieva M.A., Gaijsina E.A., Ovchinnikova E.G., Mailian O.A., Alekseev B.Y., Matveev V.B.
The possibilities of therapy of patients with metastatic colorectal cancer with BRAF V600E mutation. Clinical cases
Polyanskaya E.M., Fedyanin M.I.
Classification of breast cancer subtypes based on RNA profiling and immunohistochemical methods: clinical and biological aspects: A review
Imyanitov E.N.
Management of patients with hormone receptor-positive HER2-negative metastatic breast cancer: data of randomized trials and real-world evidence
Editorial B.
Innovations in practice. 5 years of palbociclib experience in the Russian Federation. Overview of web-conference took place on 8 October 2021
Editorial B.
Physical therapy interventions, other than general physical exercise interventions, in children and adolescents before, during and following treatment for cancer (Russian Translation of Cochrane Plain Language Summary – PLS)
Sitnikova V.A.
Comparison of afatinib and osimertinib effect on overall survival in first-line drug treatment of EGFR-positive metastatic non-small cell lung cancer: network meta-analysis
Goryaynov S.V.
Prostate cancer
Kaprin A.D., Alekseev B.I., Matveev V.B., Pushkar’ D.I., Govorov A.V., Gorban’ N.A., Kirichek A.A., Biriukov V.A., Volkova M.I., Gulidov I.A., Gumenetskaia I.V., Krylov V.V., Kariakin O.B., Krasheninnikov A.A., Mardynskii I.S., Niushko K.M., Zakharova T.I., Kostin A.A., Khmelevskii E.V., Fedenko A.A., Bolotina L.V., Falaleeva N.A., Filonenko E.V., Nevol’skikh A.A., Ivanov S.A., Khailova Z.V., Gevorkian T.G.
Isolated splenic metastases from colon cancer: clinical observations
Ognerubov N.A., Antipova T.S., Ognerubova M.A.
Prognostic role of clinical and biological factors and parameters of hormonal profile in patients with primary inoperable HER2-negative breast cancer
Samaneva N.I., Vladimirova L.I., Kolyadina I.V., Frantsiyants E.M., Storozhakova A.E., Bandovkina V.A., Kalabanova E.A., Kabanov S.N., Svetitskaya I.V., Tishina A.V., Ezhova M.O.
Vulvar cancer: brain metastases. Clinical observation
Ognerubov N.A., Antipova T.S., Kamneva N.A.
Differentiated thyroid cancer
Bel’tsevich D.G., Mudunov A.M., Vanushko V.E., Rumiantsev P.O., Mel’nichenko G.A., Kuznetsov N.S., Podvyaznikov S.O., Alymov Y.V., Poliakov A.P., Fadeev V.V., Bolotin M.V., Sevriukov F.E., Krylov V.V., Fedenko A.A., Bolotina L.V., Zharov A.A., Falaleeva N.A., Filonenko E.V., Nevol’skikh A.A., Ivanov S.A., Khailova Z.V., Gevorkian T.G.
Meta-analysis of the studies dedicated to the predictive significance of circulating tumor DNA in pancreatic cancer
Popova A.S., Fedyanin M.Y., Pokataev I.A., Tyulyandin S.A.
Virus-associated pharynx tumors in a 16-year-old boy: the description of the clinical case
Gorbunova T.V., Radtsig E.I., Merkulov O.A., Bogomil’skii M.R., Poliakov V.G.
Differential diagnosis of lung cancer and tuberculosis: review
Belova O.S., Komarov I.G.
Olaparib in the maintenance treatment of platinum-sensitive relapse of BRCA mutant ovarian cancer in routine clinical practice: first results of observational study in Russian patients
Artamonova E.V., Kovalenko E.I., Snegovoy A.V., Aksarin A.A., Anciferova T.A., Belonogov A.V., Bilan E.V., Bilenko S.N., Varvus I.M., Gorkovenko E.A., Enikeev R.F., Ermolaeva A.M., Kramskaya L.V., Kononenko I.B., Pechenyy A.P., Safina S.Z., Chupriyanova T.V., Chuhua G.G., Shemyakina A.I., Shikina E.V.
Case studies on clinical experience of targeted therapy ribociclib in combination with letrozole in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer
Frolova M.A., Kochetkova Y.I., Chubenko V.A., Volkov N.M., Moiseenko F.V., Garmarnik T.V., Ponomarenko D.M., Orlov A.E., Kostalanova Y.V., Makarycheva Y.Y., Nizegorodzeva A.A.
Dynamics of circulating tumor cells during neoadjuvant chemotherapy in patients with locally-advanced breast cancer
Nenakhova Y.N., Lyadov V.K., Poddubnaya I.V.
Eribulin for the treatment of anthracyclineand taxane-resistant breast cancer: a big step forward towards problem solving
Artamonova E.V.
The results of the treatment of patients with advanced hepatocellular carcinoma in Sverdlovsk region
Petkau V.V., Tarkhanov A.A., Kiselev E.A.
Albumin-bound paclitaxel in the treatment of metastatic breast cancer
Artamonova E.V.
Predictive biomarkers in chemotherapy of pancreatic duct adenocarcinoma: rewiew of the literature
Kovalenko Z.A., Kekeeva T.V., Lyadov V.K.
The role of nab-paclitaxel in the treatment of patients with metastatic breast cancer
Frolova M.A.
Rare morphological forms of breast cancer: features of surgical approach
Vysotskaya I.V., Letyagin V.P., Kolyadina I.V., Martynova G.V.
Neoadjuvant systemic therapy of HER2-positive breast cancer
Frolova M.A.
Intrahepatic cholangiocellular carcinoma (review)
Zharikov Y.O., Shevchenko T.V., Zhao A.V.
Russian multicenter retrospective study: preliminary data concerning clinical and molecular genetic characteristics in long-term responders to erlotinib
Smolin A.V., Gorbacheva A.V.
1 - 150 of 484 Items 1 2 3 4 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"

Согласие на обработку персональных данных с помощью сервиса «Яндекс.Метрика»

1. Я (далее – «Пользователь» или «Субъект персональных данных»), осуществляя использование сайта https://journals.rcsi.science/ (далее – «Сайт»), подтверждая свою полную дееспособность даю согласие на обработку персональных данных с использованием средств автоматизации Оператору - федеральному государственному бюджетному учреждению «Российский центр научной информации» (РЦНИ), далее – «Оператор», расположенному по адресу: 119991, г. Москва, Ленинский просп., д.32А, со следующими условиями.

2. Категории обрабатываемых данных: файлы «cookies» (куки-файлы). Файлы «cookie» – это небольшой текстовый файл, который веб-сервер может хранить в браузере Пользователя. Данные файлы веб-сервер загружает на устройство Пользователя при посещении им Сайта. При каждом следующем посещении Пользователем Сайта «cookie» файлы отправляются на Сайт Оператора. Данные файлы позволяют Сайту распознавать устройство Пользователя. Содержимое такого файла может как относиться, так и не относиться к персональным данным, в зависимости от того, содержит ли такой файл персональные данные или содержит обезличенные технические данные.

3. Цель обработки персональных данных: анализ пользовательской активности с помощью сервиса «Яндекс.Метрика».

4. Категории субъектов персональных данных: все Пользователи Сайта, которые дали согласие на обработку файлов «cookie».

5. Способы обработки: сбор, запись, систематизация, накопление, хранение, уточнение (обновление, изменение), извлечение, использование, передача (доступ, предоставление), блокирование, удаление, уничтожение персональных данных.

6. Срок обработки и хранения: до получения от Субъекта персональных данных требования о прекращении обработки/отзыва согласия.

7. Способ отзыва: заявление об отзыве в письменном виде путём его направления на адрес электронной почты Оператора: info@rcsi.science или путем письменного обращения по юридическому адресу: 119991, г. Москва, Ленинский просп., д.32А

8. Субъект персональных данных вправе запретить своему оборудованию прием этих данных или ограничить прием этих данных. При отказе от получения таких данных или при ограничении приема данных некоторые функции Сайта могут работать некорректно. Субъект персональных данных обязуется сам настроить свое оборудование таким способом, чтобы оно обеспечивало адекватный его желаниям режим работы и уровень защиты данных файлов «cookie», Оператор не предоставляет технологических и правовых консультаций на темы подобного характера.

9. Порядок уничтожения персональных данных при достижении цели их обработки или при наступлении иных законных оснований определяется Оператором в соответствии с законодательством Российской Федерации.

10. Я согласен/согласна квалифицировать в качестве своей простой электронной подписи под настоящим Согласием и под Политикой обработки персональных данных выполнение мною следующего действия на сайте: https://journals.rcsi.science/ нажатие мною на интерфейсе с текстом: «Сайт использует сервис «Яндекс.Метрика» (который использует файлы «cookie») на элемент с текстом «Принять и продолжить».